Orchid BioSciences (Nasdaq: ORCH) said on Tuesday it has signed a definitive agreement to acquire Lifecodes, a Stamford, Connecticut-based provider of identity genomics testing for forensics and ...

Bedford-based medical device maker Hologic Inc. said it has successfully completed the sale of its Lifecodes business unit to Immucor Inc. Hologic has received $85 million in cash with the opportunity ...

Recently, Hologic Inc. (HOLX) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument–reagent systems space in the blood transfusion ...

Medical device maker Hologicannounced in a press release late last week that it agreed with diagnostics maker Immucor to sell its Lifecodes business. Lifecodes, which handles transplant diagnostics, ...

Hologic Inc. of Bedford, which has operations in Marlborough, announced the sale of its Lifecodes business to Georgia-based Immucor Inc. Hologic, which develops and manufactures medical products for ...

Recently, Hologic Inc. (HOLX) inked a definitive agreement to divest its LIFECODES business unit to Immucor Inc. to focus more on its core business activities. The divestiture is expected to close ...

Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced a definitive agreement to acquire the LIFECODES business, which ...

BEDFORD, Mass., Jan. 3, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and ...

Medical device maker Hologic (HOLX-0.98%) announced in a press release late last week that it agreed with diagnostics maker Immucor to sell its Lifecodes business. Lifecodes, which handles transplant ...

Recently, Hologic Inc. ( HOLX) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument-reagent systems space in the blood transfusion ...